Morula Biotech

The Challenge

Despite decades of progress in IVF, one challenge remains unchanged: improvements to embryo quality have remained stagnant. Leaving patients with fewer opportunities, fewer transfers, and fewer chances to build the families they deserve.

The Opportunity

New advances in technology and embryology have opened the door to a different kind of IVF experience—one where outcomes can be more consistent, pathways clearer, and success more accessible. By dramatically improving how embryos grow and thrive in the lab, we can provide fertility freedom for every patient and empower clinics to deliver quality care.

The Impact

When more embryos reach their full potential, everything changes. Patients gain more chances. Clinics gain more certainty. The entire IVF journey becomes more hopeful, efficient, and sustainable. This shift isn’t just about better numbers—it’s about giving every family the strongest possible start.

Founding Team

James Cooper MEng - CEO/CTOA mechanical engineer who builds medical devices. James has taken a cell-and-gene-therapy instrument from prototype to commercial product. James brings the hardware and product experience to Morula Biotech, leading the company's engineering, operations, and the path to a device that can be manufactured and used in the clinic

Ava Harrison DPhil - CSOA reproductive scientist trained at Oxford. Ava holds a DPhil in Women's and Reproductive Health and is a graduate of the MSc in Clinical Embryology programme. Ava leads Morula Biotech's science, most recently alongside work in medical communications, shaping scientific content and strategy for pharmaceutical assets focused on fertility.